Validation of an ultra-sensitive detection method for steroid esters in plasma for doping analysis using positive chemical ionization GC-MS/MS.


Journal

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
ISSN: 1873-376X
Titre abrégé: J Chromatogr B Analyt Technol Biomed Life Sci
Pays: Netherlands
ID NLM: 101139554

Informations de publication

Date de publication:
15 Mar 2020
Historique:
received: 31 10 2019
revised: 10 02 2020
accepted: 11 02 2020
pubmed: 29 2 2020
medline: 31 3 2020
entrez: 29 2 2020
Statut: ppublish

Résumé

The standard approach to detect misuse with testosterone in sport is based on the determination and evaluation of the urinary steroid profile followed by the confirmation of atypical profiles using isotope ratio mass spectrometry. The detection capacity of these methods can be attenuated by confounding factors or testosterone preparations with endogenous isotopic fingerprints. An alternative detection method for misuse of an endogenous steroid in sports is the direct detection of the administered steroid ester present in most preparations. Thus unambiguous proof for doping misuse can be delivered. In this work, the sensitivity of gas chromatography coupled to a triple quadrupole with chemical ionization (GC-CI-MS/MS) is applied to detect trace levels of 10 testosterone and 2 nandrolone esters in plasma for in human doping analysis. The detection method was developed employing a liquid-liquid extraction and HPLC cleanup step before analysis on the GC-CI-MS/MS. The quantitative method was validated in a linear range of 100-2000 pg/ml and proved to be selective, reproducible and very sensitive with limits of detection as low as to 10 pg/ml. A clinical study with the administration of testosterone undecanoate in 3 volunteers was carried out and the compound was detectable up to 86 days after administration.

Identifiants

pubmed: 32109748
pii: S1570-0232(19)31575-2
doi: 10.1016/j.jchromb.2020.122026
pii:
doi:

Substances chimiques

Esters 0
Steroids 0
Testosterone 3XMK78S47O
testosterone undecanoate H16A5VCT9C

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122026

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Pieter Van Renterghem (P)

DoCoLab, Department of Diagnostic Sciences, Faculty of Medicine, Ghent University, Technology Park 30, 9052 Zwijnaarde, Belgium. Electronic address: pieter.vanrenterghem@ugent.be.

Wouter Viaene (W)

DoCoLab, Department of Diagnostic Sciences, Faculty of Medicine, Ghent University, Technology Park 30, 9052 Zwijnaarde, Belgium.

Wim Van Gansbeke (W)

DoCoLab, Department of Diagnostic Sciences, Faculty of Medicine, Ghent University, Technology Park 30, 9052 Zwijnaarde, Belgium.

Juliana Barrabin (J)

Laboratório Brasileiro de Controle de Dopagem, Laboratório de Apoio ao Desenvolvimento Tecnológico, Av. Horácio Macedo, 1281 - Cidade Universitária, Ilha do Fundão, Rio de Janeiro, Brazil.

Michele Iannone (M)

Laboratorio Antidoping, Federazione Medico Sportiva Italiana, Largo Onesti 1, 00197 Rome, Italy.

Michael Polet (M)

DoCoLab, Department of Diagnostic Sciences, Faculty of Medicine, Ghent University, Technology Park 30, 9052 Zwijnaarde, Belgium.

Guy T'Sjoen (G)

Department of Endocrinology, Ghent University Hospital, C. Heymanslaan 10, Ghent, Belgium.

Koen Deventer (K)

DoCoLab, Department of Diagnostic Sciences, Faculty of Medicine, Ghent University, Technology Park 30, 9052 Zwijnaarde, Belgium.

Peter Van Eenoo (P)

DoCoLab, Department of Diagnostic Sciences, Faculty of Medicine, Ghent University, Technology Park 30, 9052 Zwijnaarde, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH